The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Therapeutic goals in the treatment of Gaucher disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
SF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
The metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928
Prevalence of lysosomal storage disorders
Meikle, P. J. (1999) · JAMA · doi:10.1001/jama.281.3.249 · Cited by 2,197
Barton, N. W., Brady, R. O., Dambrosia, J. M., Di Bisceglie, A. M., Doppelt, S. H., Hill, S. C., Mankin, H. J., Murray, G. J., Parker, R. I., Argoff, C. E., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105233242104 · Cited by 1,252
Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.
Hollak, C. E., van Weely, S., van Oers, M. H., & Aerts, J. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117084 · Cited by 896 · cited 1×
“Chitotriosidase is secreted by activated macrophages (Korolenko et al., 2000), and activity in plasma is markedly increased in patients with Gaucher disease ( Hollak et al., 1994 ).”
BackgroundMetabolism of glucocerebrosides II. Evidence of an enzymatic deficiency in Gaucher's disease
Brady, R. O., Kanfer, J. N., & Shapiro, D. (1965) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(65)90743-6 · Cited by 807
The Gaucher Registry: Demographics and Disease Characteristics of 1698 Patients With Gaucher Disease
Charrow, J., Andersson, H. C., Kaplan, P., Kolodny, E. H., Mistry, P., Pastores, G., Rosenbloom, B. E., Scott, C. R., Wappner, R. S., Weinreb, N. J., et al. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.18.2835 · Cited by 574
Self-citationWeinreb, N. J., Charrow, J., Andersson, H. C., Kaplan, P., Kolodny, E. H., Mistry, P., Pastores, G., Rosenbloom, B. E., Scott, C. R., Wappner, R. S., et al. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01150-6 · Cited by 546
Self-citationAnalysis and Classification of 304 Mutant Alleles in Patients with Type 1 and Type 3 Gaucher Disease
Koprivica, V., Stone, D. L., Park, J. K., Callahan, M., Frisch, A., Cohen, I. J., Tayebi, N., & Sidransky, E. (2000) · The American Journal of Human Genetics · doi:10.1086/302925 · Cited by 334
Boot, R. G., Verhoek, M., de Fost, M., Hollak, C. E. M., Maas, M., Bleijlevens, B., van Breemen, M. J., van Meurs, M., Boven, L. A., Laman, J. D., et al. (2004) · Blood · doi:10.1182/blood-2003-05-1612 · Cited by 334
Self-citationTayebi, N. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00071-4 · Cited by 327
X‐ray structure of human acid‐β‐glucosidase, the defective enzyme in Gaucher disease
Dvir, H., Harel, M., McCarthy, A. A., Toker, L., Silman, I., Futerman, A. H., & Sussman, J. L. (2003) · EMBO reports · doi:10.1038/sj.embor.embor873 · Cited by 278
Skeletal aspects of Gaucher disease: a review
Wenstrup, R. J., Roca-Espiau, M., Weinreb, N. J., & Bembi, B. (2002) · The British Journal of Radiology · doi:10.1259/bjr.75.suppl_1.750002 · Cited by 273
Self-citationDesforges, J. F., & Beutler, E. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111073251906 · Cited by 252
Cox, T. M., Aerts, J. M. F. G., Andria, G., Beck, M., Belmatoug, N., Bembi, B., Chertkoff, R., Vom Dahl, S., Elstein, D., Erikson, A., et al. (2003) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1025902113005 · Cited by 236
Self-citationRosenthal, D. I., Doppelt, S. H., Mankin, H. J., Dambrosia, J. M., Xavier, R. J., McKusick, K. A., Rosen, B. R., Baker, J., Niklason, L. T., Hill, S. C., et al. (1995) · Pediatrics · doi:10.1542/peds.96.4.629 · Cited by 190
Enzyme therapy for Gaucher disease: the first 5 years
Grabowski, G. A., Leslie, N., & Wenstrup, R. (1998) · Blood Reviews · doi:10.1016/s0268-960x(98)90023-6 · Cited by 188
Self-citationMistry, P. K., Sirrs, S., Chan, A., Pritzker, M. R., Duffy, T. P., Grace, M. E., Meeker, D. P., & Goldman, M. E. (2002) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(02)00122-1 · Cited by 175
Self-citationGaucher disease type 1: Revised recommendations on evaluations and monitoring for adult patients
Weinreb, N. J., Aggio, M. C., Andersson, H. C., Andria, G., Charrow, J., Clarke, J. T. R., Erikson, A., Giraldo, P., Goldblatt, J., Hollak, C., et al. (2004) · Seminars in Hematology · doi:10.1053/j.seminhematol.2004.07.010 · Cited by 171
Self-citationEnzyme replacement therapy for Gaucher disease
Beutler, E., Kay, A., Saven, A., Garver, P., Thurston, D., Dawson, A., & Rosenbloom, B. (1991) · Blood · doi:10.1182/blood.v78.5.1183.1183 · Cited by 169
Charrow, J., Esplin, J. A., Gribble, T. J., Kaplan, P. B., Kolodny, E. H., Pastores, G. M., Scott, C. R., Wappner, R. S., Weinreb, N. J., & Wisch, J. S. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.16.1754 · Cited by 155
Self-citationTwin pairs showing discordance of phenotype in adult Gaucher's disease
Lachmann, R., Grant, I. R., Halsall, D. J., & Cox, T. M. (2004) · QJM · doi:10.1093/qjmed/hch036 · Cited by 155
Self-citation4 Plasma and metabolic abnormalities in Gaucher's disease
Aerts, J. M. F. G., & Hollak, C. E. M. (1997) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(97)80034-0 · Cited by 153
Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease
Deegan, P. B., Moran, M. T., McFarlane, I., Schofield, J. P., Boot, R. G., Aerts, J. M. F. G., & Cox, T. M. (2005) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2005.05.005 · Cited by 137
Self-citationIndividualization of long-term enzyme replacement therapy for Gaucher disease
Andersson, H. C., Charrow, J., Kaplan, P. B., Mistry, P. K., Pastores, G. M., Prakash‐Cheng, A., Rosenbloom, B. E., Scott, C. R., Wappner, R. S., & Weinreb, N. J. (2005) · Genetics in Medicine · doi:10.1097/01.gim.0000153660.88672.3c · Cited by 128
Self-citationEnzyme Therapy for Lysosomal Storage Disease: Principles, Practice, and Prospects
Grabowski, G. A., & Hopkin, R. J. (2003) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.4.070802.110415 · Cited by 127
Self-citationDivergent phenotypes in Gaucher disease implicate the role of modifiers
Göker-Alpan, Ö., Hruska, K. S., Orvisky, E., Kishnani, P. S., Stubblefield, B. K., Schiffmann, R., & Sidransky, E. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.028019 · Cited by 124
X-ray Structure of Human Acid-β-Glucosidase Covalently Bound to Conduritol-B-Epoxide
Premkumar, L., Sawkar, A. R., Boldin‐Adamsky, S., Toker, L., Silman, I., Kelly, J. W., Futerman, A. H., & Sussman, J. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502799200 · Cited by 118
Echocardiographic assessment of pulmonary hypertension in Gaucher's disease
Elstein, D., Klutstein, M. W., Lahad, A., Abrahamov, A., Hadas‐Halpern, I., & Zimran, A. (1998) · The Lancet · doi:10.1016/s0140-6736(98)10194-0 · Cited by 110
Massive hepatic fibrosis in Gaucher's disease: clinico-pathological and radiological features
Lachmann, R. (2000) · QJM · doi:10.1093/qjmed/93.4.237 · Cited by 102
Acceleration of retarded growth in children with Gaucher disease after treatment with alglucerase
Kaplan, P. B., Mazur, A. T., Manor, O., Charrow, J., Esplin, J. A., Gribble, T. J., Wappner, R. S., Wisch, J. S., & Weinreb, N. J. (1996) · The Journal of Pediatrics · doi:10.1016/s0022-3476(96)70203-2 · Cited by 101
Self-citationResponse of Gaucher bone disease to enzyme replacement therapy
Poll, L. W., Maas, M. M., Terk, M. R., et al. (2002) · British Journal of Radiology · doi:10.1259/bjr.75.suppl_1.750025 · Cited by 99
Schueler, U., Kolter, T., Kaneski, C. R., Blusztajn, J. K., Herkenham, M. A., Sandhoff, K., & Brady, R. O. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.016 · Cited by 96
McCabe, E. R. B. (1996) · JAMA · doi:10.1001/jama.1996.03530310054033 · Cited by 90
Damiano, A. M., Pastores, G. M., & Ware, J. E. (1998) · Quality of Life Research · doi:10.1023/a:1008814105603 · Cited by 87
Self-citationHollak, C. E. M., Maas, M. M., Akkerman, E. M., den Heeten, A., & Aerts, J. M. F. G. (2001) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2001.0474 · Cited by 84
Binding, internalization, and degradation of mannose-terminated glucocerebrosidase by macrophages.
Sato, Y., & Beutler, E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116409 · Cited by 80
Clinically relevant therapeutic endpoints in type I Gaucher disease
Hollak, C. E. M., Maas, M. M., & Aerts, J. M. F. G. (2001) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1012492429191 · Cited by 74
Kauli, R., Zaizov, R., Lazar, L., Pertzelan, A., Laron, Z., Galatzer, A., Phillip, M., Yaniv, Y., & Cohen, I. J. (2000) · PubMed · Cited by 65
Young, E. P., Chatterton, C., Vellodi, A., & WINCHESTER, B. G. (1997) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005367328003 · Cited by 63
Cabrera-Salazar, M., O'Rourke, E., Henderson, N., Wessel, H., & Barranger, J. (2004) · Clinica chimica acta; international journal of clinical chemistry · doi:10.1016/j.cccn.2004.02.018 · Cited by 62
Quantitative Analysis of the Targeting of Mannose‐Terminal Glucocerebrosidase
Bijsterbosch, M. K., Donker‐Koopman, W. E., van de Bilt, H., van Weely, S., van Berkel, T. J. C., & Aerts, J. M. F. G. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00344.x · Cited by 61
A neurological symptom survey of patients with type I Gaucher disease
Pastores, G. M., Barnett, N. L., Bathan, P., & Kolodny, E. H. (2003) · Journal of Inherited Metabolic Disease · doi:10.1023/b:boli.0000005623.60471.51 · Cited by 61
Self-citationPoll, L. W., Koch, J.-A., Willers, R., Aerts, J. M. F. G., Scherer, A., Häussinger, D., Mödder, U., & Dahl, S. V. (2002) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2002.0511 · Cited by 59
Giraldo, P., Cenarro, A., Alfonso, P., Pérez‐Calvo, J. I., Rubio-Félix, D., Giralt, M., & Pocoví, M. (2001) · PubMed · Cited by 55
Self-citationSerum ferritin concentration in Gaucher's disease.
Morgan, M. A., Hoffbrand, A. V., Laulicht, M., Luck, W., & Knowles, S. (1983) · BMJ · doi:10.1136/bmj.286.6381.1864 · Cited by 47
Czartoryska, B., Tylki‐Szymańska, A., & Ługowska, A. (2000) · Clinical Biochemistry · doi:10.1016/s0009-9120(99)00098-3 · Cited by 40
Self-citationZhu, Y., Li, X., Schuchman, E. H., Desnick, R. J., & Cheng, S. H. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060236 · Cited by 37
Cited by
A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
Stirnemann, J., Belmatoug, N., Camou, F., Serratrice, C., Froissart, R., Caillaud, C., Levade, T., Astudillo, L., Serratrice, J., Brassier, A., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020441 · Cited by 868
Phenotype, diagnosis, and treatment of Gaucher's disease
Grabowski, G. A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61522-6 · Cited by 634
Self-citationPastores, G. M. (2012) · Swaiman's Pediatric Neurology · doi:10.1016/b978-1-4377-0435-8.00036-6 · Cited by 633
Self-citationGaucher disease: pathological mechanisms and modern management
Jmoudiak, M., & Futerman, A. H. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05351.x · Cited by 288
Lysosomal storage disease overview
Sun, A. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.11.39 · Cited by 271
Metadata
- Authors
- Pastores, G. M., Weinreb, N. J., Aerts, H., Andria, G., Cox, T. M., Giralt, M., Grabowski, G. A., Mistry, P. K., & Tylki-Szymańska, A.
- Venue
- Seminars in Hematology
- Publisher
- Elsevier BV
- Published
- 2004-10
- Volume
- 41
- Issue
- 4 Suppl 5
- Pages
- 4-14
- ISSN
- 0037-1963 (ISSN-L)
- OpenAlex
- W2104607370
- Cited by
- 422
- References
- 49
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.